Register early and save! Early registration rates end 10 April 2023
 
Register   early and save! Early registration rates end 10 April 2023.

 

Conference Attendees

RAPS Euro Convergence provides essential knowledge in the medical device, IVD, pharmaceutical industries, and regulatory business that will prepare you to successfully navigate the EU regulatory landscape.

 

RAPS Euro Convergence 2023 will focus on Harmonisation Through Regulatory Confluence

The regulatory affairs profession has seen a significant increase in regulations surrounding healthcare products—not only in the EU but across the globe. As such, this drives diverse interpretations and implementations in country and market strategies. Now more than ever, stakeholders across medical devices, IVDs, pharmaceuticals, and combination products must come together for open exchanges to manage the availability of safe and effective patient care.

RAPS Euro Convergence 2023 will focus on uniting global regulators, notified bodies, competent authorities, key opinion leaders, patient interest groups, and industry partners to explore varying perspectives about the current regulatory landscape and MDR/IVDR rollouts. Across three days of interactive discussions, the hope is to achieve a confluence among stakeholders that accelerates innovation.

Don’t miss the opportunity to contribute and engage in this critical dialogue. Register today to attend RAPS Euro Convergence 2023!

 
 

2023 RAPS Euro Convergence Programme Committee

Co-Chairs

 
Alex Laan
Alex Laan
Head of IVD Notified Body,
BSI Group The Netherlands B.V.
Siegfried Schmitt
Siegfried Schmitt
Vice President, Technical,
PAREXEL
 

 

Committee Members

 
Philippe Auclair
Robert Van Boxtel

Principal Consultant Medical Device Project B.V.

Giovanni Di Rienzo
Giovanni Di Rienzo

Senior Consultant,
Qserve

Mats Ericson
Beate Schmidt

Consultant Regulatory Affairs

Gert Bos
Gert Bos

Executive Director and Partner, QServe Group

Sabina Hoekstra-van den Bosch
Sabina Hoekstra-van den Bosch

Regulatory Strategy Principal, TÜV SÜD

Susana Waesch
Susana de Azevedo  Wäsch

Vice President Quality Management and Regulatory Affairs, Ypsomed

Magdalena Bujar
Magda Bujar

Manager, Strategic Development, Centre for Innovation in Regulatory Science

Eric Klasen
Eric Klasen

Life Sciences expert in Regulatory & QA solutions

Anja Wiersma
Anja Wiersma

CEO and Senior Consultant, mi-CE Consultancy

Rosie Dawes
Charlie Mortazavi

Associate Director, Global Regulatory Affairs, Established Products, Alexion Pharmaceuticals

Leo Louis
Leo Louis

Senior Regulatory Affairs Manager, Philips International B.V.

Marie-Paule Dubaele
Jennifer Neff 

Director, Scientific, Clinical & Regulatory Affairs, bitop AG

Irena Medarevic-Milobratovic
Kate Stockman 

Senior Director, Haleon 

 

Advisor

 
Sabine Haubenreisser
Sabine Haubenreisser (EMA)

Principal Scientific Administrator, European Medicines Agency